Single-Photon Emission Computed Tomography Market Outlook (2022 to 2032)

The global single-photon emission computed tomography market size reached USD 2.28 Billion in 2021 and it is expected to enjoy a valuation of USD 2.45 Billion by the end of 2022. Furthermore, with the rising prevalence of various cardiovascular diseases and the growing need for better diagnostic technologies, the overall demand for single-photon emission computed tomography (SPECT) is poised to grow at 6.9% CAGR between 2022 and 2032, totaling a market valuation of ~USD 4.76 Billion by 2032.

Based on product, the single imaging gamma cameras segment dominated the global single-photon emission computed tomography market with a market share of about 75.5% in 2021 and it is likely to retain its dominance during the projected period.

Single-photon emission computed tomography is a potential nuclear medicine technique that produces 3-D images of functional processes in the human body while allowing non-invasive diagnostic imaging of metabolic processes using short-lived radioisotopes. Applications for single-photon emission computed tomography scanners are numerous and one key application is the detection of chronic illnesses.

Nuclear imaging apparatus includes single-photon emission computed tomography imaging systems. Single-photon emission computed tomography is used to assess the metabolic and functional data of cells and organs as it relates to disease processes. Enhancing various equipment's diagnostic capabilities in organic-specific or dual-modality systems has recently been crucial, and is anticipated to fuel market expansion during the projection period.

Attribute Key Statistics
Single Photo Emission Computed Tomography Market Base Value (2021) USD 2.28 Billion
Estimated Market Value (2022) USD 2.45 Billion
Projected Market Value (2032) USD 4.76 Billion
Value-based CAGR (2022 to 2032) 6.9%
Market Share of Top 5 Countries 59.3%

The single-photon emission computed tomography (SPECT) systems market is driven by the rising prevalence of cancer, neurological diseases, and cardiovascular diseases.

Similarly, rising patient awareness, an increasing number of initiatives for research and development, and a rise in demand for diagnostic imaging devices such as MRI and X-ray devices are expected to boost the market during the forecast period. The overall single-photon emission computed tomography holds approximately 6.1% of the global medical imaging market which stood at USD 37.2 Billion in 2021.

Sales Analysis of Single-Photon Emission Computed Tomography Market from 2012 to 2021 vs. Market Outlook for 2022 to 2032

The global single-photon emission computed tomography market expanded at a CAGR of 5.4% during the historic period from 2012 to 2021. However, with the growing demand for effective diagnostic techniques, the overall sales of single-photon emission computed tomography products are likely to grow at 6.9% CAGR through 2032.

Demand for single-photon emission computed tomography scanners in cancer diagnosis has increased significantly over the past few years and the trend is likely to continue during the forecast period. The technology offers a sophisticated diagnostic tool that helps in early disease diagnosis coupled with the capability to detect disease progression at each stage.

Cancer is one of the leading causes of death in many countries around the globe, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.

Industry experts have noted that the diagnostic accuracy of single-photon emission computed tomography scanners in certain clinical oncological examinations such as lung cancer, prostate cancer, colorectal cancer, melanoma, and several other cancers is higher than other diagnostic imaging techniques.

Manufacturers are concentrating on integrating several technological advancements into their single-photon emission computed tomography scanning machines, including higher storage capacity and increased efficiency about faster scanning times.

From a business perspective, increased data storage will enable physicians to archive more information from patients' prior scans, track tumor development over the course of a patient's disease prognosis, and perform more scans per day, increasing the financial viability of single-photon emission computed tomography scanners in the nuclear medicine industry.

What are the Key Trends Driving the Global Single-Photon Emission Computed Tomography Market?

Growing Application of Single-Photon Emission Computed Tomography in Various Medical Fields and Advancements in radiopharmacy to Boost Market

Globally, single-photon emission computed tomography (SPECT) and X-ray transmission computed tomography (CT) scan hybrid imaging is becoming more popular. With the exact attenuation correction and fusion imaging that this cutting-edge technology offers, diagnostic sensitivity, and specificity are increased.

By defining prognostic and treatment monitoring capabilities and metabolic information provided by traditional nuclear imaging methods, the combination of SPECT and CT aids in improved disease staging. As a result, SPECT/CT has increasingly been used in clinical tests, particularly in the areas of musculoskeletal, cardiology, endocrinology, cancer, infection, and others.

Due to their use in creating a customized treatment plan for individualized treatment, multimodality imaging techniques will further change diagnostic imaging procedures in the future.

The practice of nuclear medicine has changed dramatically over the past ten years as a result of amazing developments in radiopharmacy, instrumentation, and information technology, all of which have played significant roles in fostering the field's expansion.

The field of nuclear medicine has been revived by new technologies like PET/CT and SPECT/CT. It is also anticipated that the development of novel radiopharmaceuticals and other hybrid modalities, like SPECT/MRI, would spur the development of new diagnostic and therapeutic uses.

All the above scenarios offer a great opportunity for market growth during the forecast period from 2022 to 2032.

What are the Factors Restraining Growth of the Single-Photon Emission Computed Tomography Market?

The expansion of the single-photon emission computed tomography market over the projection period may be constrained by the lower availability and insufficient supply of molecular isotopes, which are necessary for diagnostic imaging devices.

For instance, there have been numerous supply shortages for technetium and molybdenum during the past few years, which are used in the bulk of SPECT operations in cardiology. Due to aging and safety concerns, the Canadian reactors that supply the molecular isotopes were permanently shut down in 2016, which limited the supply.

The field of nuclear medicine imaging has reached milestones with the advent of hybrid/fusion scanners which are paving the way to a new era in the field of imaging.

The introduction of new radiation detector systems in nuclear medicine imaging has led to a multifold increase in sensitivity and energy resolution. With the use of CZT (cadmium zinc telluride) detectors, SPECT/CT is likely to become organ-specific.

Similarly, the higher price of SPECT devices, such as SPECT-CT, SPECT-MRI, and the integration and combination of various diagnostics and imaging devices is usually a major cost restraint for the single-photon emission computed tomography market.

Only professionals who are trained within the healthcare domain for day-to-day operations and maintenance can work on single-photon emission computed tomography devices. Globally, the demand for SPECT devices is increasing. The shortage of trained specialists and professionals will hamper the growth of the global single-photon emission computed tomography market over the forecast period.

These factors cumulatively propose a negative effect on the developmental growth of the single-photon emission computed tomography market.

Country-wise Insights

What Makes the USA a Highly Lucrative Market for Single-Photon Emission Computed Tomography?

Presence of Favourable Reimbursement Policies Boosting Market in the USA

The USA holds approximately 38.0% share in the global single-photon emission computed tomography market in 2021 and is projected to grow at a robust pace during the forecast period.

Favorable reimbursement for nuclear medicine devices and treatment is increasing in North America which is expected to boost the growth of the United States of America single-photon emission computed tomography market.

The percentage of the total payor mix from private/self-pay revenue increased from 66.5% in 2018 to 67.4% in 2020. The Medicare percentage decreased from 21.8% to 20.5%.

What Makes China a Lucrative Single-Photon Emission Computed Tomography Market?

Rapid Expansion of Healthcare Infrastructure Generating demand in China

With a market share of over 5.3% in 2021 in the global market, China's single-photon emission computed tomography market is anticipated to grow at a healthy pace throughout the forecast period.

This expansion is attributed to the country's fast-developing medical infrastructure, an increase in scientific research on the diagnosis, treatment, and follow-up of chronic illnesses, as well as significant support from the public and commercial sectors for cancer research.

What is the Growth Projection for German Single-Photon Emission Computed Tomography Market?

Rising Geriatric Population Driving Market in Germany

As per FMI, Germany is set to hold a market share of nearly 5.0% in the global single-photon emission computed tomography market during the forecast period owing to an increase in the elderly population, increased prevalence of cancer, clinical usage of diagnostics techniques that use radiopharmaceuticals and increasing funding from the government.

40-59-year-olds make up the largest age group in Germany, at 23 million people. The most recent figures from 2021 confirm that the next-largest age group was 65 years and older, at 18.44 million.

Category-wise Insights

Which is the Most Commonly Used Product in Single-Photon Emission Computed Tomography Market?

Demand to Remain High for Single Imaging Cameras

The single imaging gamma cameras segment held a market share of about 75.5% in the global market in 2021 and it is expected to grow at a CAGR of 6.3% throughout the forecast period.

The most used imaging tool in nuclear medicine is the gamma camera, often known as a scintillation camera. It allows the capture of both dynamic and static images of the area of interest in the human body. Thus single-imaging gamma cameras are ahead of other products in the single-photon emission computed tomography market.

Which is the Most Lucrative Application for Single-Photon Emission Computed Tomography?

Growing Popularity of SPECT in Cardiology to Generate Maximum Revenues

Based on application, the cardiology segment held a revenue share of around 36.6% in the global single photon emission computed tomography market in 2021 and is expected to expand at a moderate growth rate over the forecast period.

Cardiologists utilize single-photon emission computed tomography to see how the blood flows through various areas of the heart. Doctors can see where and how well blood flows into and around the heart by injecting a radioactive tracer (such as technetium or sestamibi) that has been marked with gamma cameras.

In this ailment, medical professionals determine whether a patient's heart has been negatively affected by conditions such as hypertension, coronary artery disease, atherosclerosis (artery hardening), valvular diseases like mitral valve prolapse, congenital bicuspid valves brought on by infection in early childhood, etc.

Which is the Leading End User of Single-Photon Emission Computed Tomography Products?

Most of the SPECT Product Sales Remain Concentrated in Hospitals

The hospital's segment held a 56.9% market share in the single-photon emission computed tomography market in 2021 and it is expected to grow at a CAGR of 7.6% during the forecast period, owing to the easy access and availability of SPECT products across hospitals for cardiology and oncology treatments.

The SPECT market will boost due to a large number of patients being admitted to the hospital for seeking treatment. The availability of advanced medical equipment with improved efficiency and technology along with trained staff and healthcare professionals add to the high growth of this segment.

Similarly, the presence of advanced medical equipment attracts a large number of patients to come to hospitals to seek treatment and get maximum satisfaction and relief. Thus hospitals are ahead of other end users in the single-photon emission computed tomography market.

Competitive Landscape

To establish a dominant position in the market, major players in the single-photon emission computed tomography market are aggressively concentrating on partnerships, product launches, and expansion.

For instance

  • In November 2020, GE Healthcare announced its acquisition of Prismatic Sensors AB, a Swedish startup specializing in photon-counting detectors, signifying the company’s continued investment in photon-counting CT technology.
  • In May 2022, Mediso Ltd announced the acquisition of Bartec Technologies Ltd, UK based company specializing in the supply, installation, and support of Nuclear Medicine and Molecular Imaging equipment and accessories.

Report Scope as per Single-photon Emission Computed Tomography Industry Analysis

Attribute Details
Estimated Market Size (2022) USD 2.45 Billion
Projected Market Size (2032) USD 4.76 Billion
Anticipated Growth Rate (2022 to 2032) 6.9%
Forecast Period 2012 to 2021
Historical Data Available for 2022 to 2032
Market Analysis USD Million for Value
Key Regions Covered North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, Russia, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, Israel, North Africa, and South Africa
Key Market Segments Covered Product, Application, End User, and Region
Key Companies Profiled Bruker Corp.; DDD-Diagnostic AS; Digmed Corp.; General Electric Co.; Mediso Ltd.; MiE GmbH; MILabs BV; Siemens Healthineers AG; Spectrum Dynamics Medical Inc.; GE Healthcare; CardiArc; Beijing Hamamatsu Photon Techniques INC.; SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.; PNPMed; NuCare Inc.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Key Market Segments Covered in Single-photon Emission Computed Tomography Industry Research

By Product:

  • Single Imaging Gamma Cameras
  • SPECT/CT

By Application:

  • Cardiology
  • Oncology
  • Neurology
  • Others

By End User:

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Key Success Factors
  • 5. Market Background
  • 6. Global market Demand Volume (Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032
  • 7. Global Market - Pricing Analysis
  • 8. Global market Demand (in Value or Size in USD Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
  • 9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
    • 9.1. Single Imaging Gamma Cameras
    • 9.2. SPECT/CT
  • 10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application
    • 10.1. Cardiology
    • 10.2. Oncology
    • 10.3. Neurology
    • 10.4. Others
  • 11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
    • 11.1. Hospitals
    • 11.2. Diagnostic Imaging Centers
    • 11.3. Ambulatory Surgical Centers
  • 12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region
    • 12.1. North America
    • 12.2. Latin America
    • 12.3. Europe
    • 12.4. East Asia
    • 12.5. South Asia
    • 12.6. Oceania
    • 12.7. Middle East and Africa (MEA)
  • 13. North America market Analysis 2012 to 2021 and Forecast 2022 to 2032
  • 14. Latin America market Analysis 2012 to 2021 and Forecast 2022 to 2032
  • 15. Europe market Analysis 2012 to 2021 and Forecast 2022 to 2032
  • 16. South Asia market Analysis 2012 to 2021 and Forecast 2022 to 2032
  • 17. East Asia market Analysis 2012 to 2021 and Forecast 2022 to 2032
  • 18. Oceania market 2012 to 2021 and Forecast 2022 to 2032
  • 19. Middle East and Africa (MEA) market Analysis 2012 to 2021 and Forecast 2022 to 2032
  • 20. Market Structure Analysis
  • 21. Competition Analysis
    • 21.1. Koninklijke Philips NV
    • 21.2. Bruker Corp.
    • 21.3. DDD-Diagnostic AS
    • 21.4. Digirad Corp.
    • 21.5. General Electric Co.
    • 21.6. Mediso Ltd.
    • 21.7. MiE GmbH
    • 21.8. MILabs BV
    • 21.9. Siemens Healthineers AG
    • 21.10. Spectrum Dynamics Medical Inc.
    • 21.11. GE Healthcare
    • 21.12. CardiArc
    • 21.13. Beijing Hamamatsu Photon Techniques INC.
    • 21.14. SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
    • 21.15. PNPMed
    • 21.16. NuCare Inc.
  • 22. Assumptions and Acronyms Used
  • 23. Research Methodology

List of Tables

Table 01: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 02: Global Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 03: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 04: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

Table 05: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Region

Table 06: North America Market Value (US$ Million) Analysis 2012 to 2032and Forecast 2022 to 2032, by Country

Table 07: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 08: North America Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 09: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 10: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

Table 11: Latin America Market Value (US$ Million) Analysis 2012 to 2032and Forecast 2022 to 2032, by Country

Table 12: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 13: Latin America Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 15: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

Table 16: Europe Market Value (US$ Million) Analysis 2012 to 2032and Forecast 2022 to 2032, by Country

Table 17: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 18: Europe Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 19: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

Table 21: South Asia Market Value (US$ Million) Analysis 2012 to 2032and Forecast 2022 to 2032, by Country

Table 22: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 23: South Asia Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 24: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 25: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

Table 26: East Asia Market Value (US$ Million) Analysis 2012 to 2032and Forecast 2022 to 2032, by Country

Table 27: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 28: East Asia Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 29: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 30: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

Table 31: Oceania Market Value (US$ Million) Analysis 2012 to 2032and Forecast 2022 to 2032, by Country

Table 32: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 33: Oceania Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 34: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 35: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

Table 36: MEA Market Value (US$ Million) Analysis 2012 to 2032and Forecast 2022 to 2032, by Country

Table 37: MEA Market Value (US$ Million) Analysis and Forecast 2012 to 2032, By Product

Table 38: MEA Market Volume (Units) Analysis and Forecast 2012 to 2032, By Product

Table 39: MEA Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by Application

Table 40: MEA Market Value (US$ Million) Analysis and Forecast 2012 to 2032, by End User

List of Figures

Figure 01: Global  Volume (Units), 2012 to 2021

Figure 02: Global  Volume (Units) & Y-o-Y Growth (%) Analysis, 2022 to 2032

Figure 03: , Pricing Analysis per unit (US$), in 2022

Figure 04: , Pricing Forecast per unit (US$), in 2032

Figure 05: Global  Value (US$ Million) Analysis, 2012 to 2021

Figure 06: Global  Forecast & Y-o-Y Growth, 2022 to 2032

Figure 07: Global  Absolute $ Opportunity (US$ Million) Analysis, 2021 to 2032

Figure 08: Global  Value Share (%) Analysis 2022 and 2032, By Product

Figure 09: Global  Y-o-Y Growth (%) Analysis 2021 to 2032, By Product

Figure 10: Global  Attractiveness Analysis 2022 to 2032, By Product

Figure 11: Global  Value Share (%) Analysis 2022 and 2032, by Application

Figure 12: Global  Y-o-Y Growth (%) Analysis 2021 to 2032, by Application

Figure 13: Global  Attractiveness Analysis 2022 to 2032, by Application

Figure 14: Global  Value Share (%) Analysis 2022 and 2032, by End User

Figure 15: Global  Y-o-Y Growth (%) Analysis 2021 to 2032, by End User

Figure 16: Global  Attractiveness Analysis 2022 to 2032, by End User

Figure 17: Global  Value Share (%) Analysis 2022 and 2032, by Region

Figure 18: Global  Y-o-Y Growth (%) Analysis 2021 to 2032, by Region

Figure 19: Global  Attractiveness Analysis 2022 to 2032, by Region

Figure 20: North America  Value (US$ Million) Analysis, 2012 to 2021

Figure 21: North America  Value (US$ Million) Forecast, 2022 to 2032

Figure 22: North America  Value Share, By Product (2022 E)

Figure 23: North America  Value Share, by Application (2022 E)

Figure 24: North America  Value Share, by End User (2022 E)

Figure 25: North America  Value Share, by Country (2022 E)

Figure 26: North America  Attractiveness Analysis, By Product, 2022 to 2032

Figure 27: North America  Attractiveness Analysis, By Application, 2022 to 2032

Figure 28: North America  Attractiveness Analysis, By End User, 2022 to 2032

Figure 29: North America  Attractiveness Analysis, By Country, 2022 to 2032

Figure 30: USA.  Value Proportion Analysis, 2022

Figure 31: Global Vs. USAGrowth Comparison, 2021 to 2032

Figure 32: USA  Share Analysis (%) By Product, 2021 to 2032

Figure 33: USA  Share Analysis (%) by Application, 2021 to 2032

Figure 34: USA  Share Analysis (%) by End User, 2021 to 2032

Figure 35: Canada  Value Proportion Analysis, 2022

Figure 36: Global Vs. Canada. Growth Comparison, 2021 to 2032

Figure 37: Canada  Share Analysis (%) By Product, 2021 to 2032

Figure 38: Canada  Share Analysis (%) by Application, 2021 to 2032

Figure 39: Canada  Share Analysis (%) by End User, 2021 to 2032

Figure 40: Latin America  Value (US$ Million) Analysis, 2012 to 2021

Figure 41: Latin America  Value (US$ Million) Forecast, 2022 to 2032

Figure 42: Latin America  Value Share, By Product (2022 E)

Figure 43: Latin America  Value Share, by Application (2022 E)

Figure 44: Latin America  Value Share, by End User (2022 E)

Figure 45: Latin America  Value Share, by Country (2022 E)

Figure 46: Latin America  Attractiveness Analysis, By Product, 2022 to 2032

Figure 47: Latin America  Attractiveness Analysis, By Application, 2022 to 2032

Figure 48: Latin America  Attractiveness Analysis, By End User, 2022 to 2032

Figure 49: Latin America  Attractiveness Analysis, By Country, 2022 to 2032

Figure 50: Mexico  Value Proportion Analysis, 2022

Figure 51: Global Vs. Mexico Growth Comparison, 2021 to 2032

Figure 52: Mexico  Share Analysis (%) By Product, 2021 to 2032

Figure 53: Mexico  Share Analysis (%) by Application, 2021 to 2032

Figure 54: Mexico  Share Analysis (%) by End User, 2021 to 2032

Figure 55: Brazil  Value Proportion Analysis, 2021

Figure 56: Global Vs. Brazil. Growth Comparison, 2021 to 2032

Figure 57: Brazil  Share Analysis (%) By Product, 2021 to 2032

Figure 58: Brazil  Share Analysis (%) by Application, 2021 to 2032

Figure 59: Brazil  Share Analysis (%) by End User, 2021 to 2032

Figure 60: Argentina  Value Proportion Analysis, 2022

Figure 61: Global Vs. Argentina Growth Comparison, 2021 to 2032

Figure 62: Argentina  Share Analysis (%) By Product, 2021 to 2032

Figure 63: Argentina  Share Analysis (%) by Application, 2021 to 2032

Figure 64: Argentina  Share Analysis (%) by End User, 2021 to 2032

Figure 65: Europe  Value (US$ Million) Analysis, 2012 to 2021

Figure 66: Europe  Value (US$ Million) Forecast, 2022 to 2032

Figure 67: Europe  Value Share, By Product (2022 E)

Figure 68: Europe  Value Share, by Application (2022 E)

Figure 69: Europe  Value Share, by End User (2022 E)

Figure 70: Europe  Value Share, by Country (2022 E)

Figure 71: Europe  Attractiveness Analysis, By Product, 2022 to 2032

Figure 72: Europe  Attractiveness Analysis, By Application, 2022 to 2032

Figure 73: Europe  Attractiveness Analysis, By End User, 2022 to 2032

Figure 74: Europe  Attractiveness Analysis, By Country, 2022 to 2032

Figure 75: UK  Value Proportion Analysis, 2022

Figure 76: Global Vs. UK Growth Comparison, 2021 to 2032

Figure 77: UK  Share Analysis (%) By Product, 2021 to 2032

Figure 78: UK  Share Analysis (%) by Application, 2021 to 2032

Figure 79: UK  Share Analysis (%) by End User, 2021 to 2032

Figure 80: Germany  Value Proportion Analysis, 2022

Figure 81: Global Vs. Germany Growth Comparison, 2021 to 2032

Figure 82: Germany  Share Analysis (%) By Product, 2021 to 2032

Figure 83: Germany  Share Analysis (%) by Application, 2021 to 2032

Figure 84: Germany  Share Analysis (%) by End User, 2021 to 2032

Figure 85: Italy  Value Proportion Analysis, 2022

Figure 86 Global Vs. Italy Growth Comparison, 2021 to 2032

Figure 87: Italy  Share Analysis (%) By Product, 2021 to 2032

Figure 88: Italy  Share Analysis (%) by Application, 2021 to 2032

Figure 89: Italy  Share Analysis (%) by End User, 2021 to 2032

Figure 90: France  Value Proportion Analysis, 2021

Figure 91: Global Vs. France Growth Comparison, 2021 to 2032

Figure 92: France  Share Analysis (%) By Product, 2021 to 2032

Figure 93: France  Share Analysis (%) by Application, 2021 to 2032

Figure 94: France  Share Analysis (%) by End User, 2021 to 2032

Figure 95: Spain  Value Proportion Analysis, 2022

Figure 96: Global Vs. Spain Growth Comparison, 2021 to 2032

Figure 97: Spain  Share Analysis (%) By Product, 2021 to 2032

Figure 98: Spain  Share Analysis (%) by Application, 2021 to 2032

Figure 99: Spain  Share Analysis (%) by End User, 2021 to 2032

Figure 100: Russia  Value Proportion Analysis, 2022

Figure 101: Global Vs. Russia Growth Comparison, 2021 to 2032

Figure 102: Russia  Share Analysis (%) By Product, 2021 to 2032

Figure 103: Russia  Share Analysis (%) by Application, 2021 to 2032

Figure 104: Russia  Share Analysis (%) by End User, 2021 to 2032

Figure 105: BENELUX  Value Proportion Analysis, 2022

Figure 106: Global Vs. BENELUX Growth Comparison, 2021 to 2032

Figure 107: BENELUX  Share Analysis (%) By Product, 2021 to 2032

Figure 108: BENELUX  Share Analysis (%) by Application, 2021 to 2032

Figure 109: BENELUX  Share Analysis (%) by End User, 2021 to 2032

Figure 110: East Asia  Value (US$ Million) Analysis, 2012 to 2021

Figure 111: East Asia  Value (US$ Million) Forecast, 2022 to 2032

Figure 112: East Asia  Value Share, By Product (2022 E)

Figure 113: East Asia  Value Share, by Application (2022 E)

Figure 114: East Asia  Value Share, by End User (2022 E)

Figure 115: East Asia  Value Share, by Country (2022 E)

Figure 116: East Asia  Attractiveness Analysis, By Product, 2022 to 2032

Figure 117: East Asia  Attractiveness Analysis, By Application, 2022 to 2032

Figure 118: East Asia  Attractiveness Analysis, By End User, 2022 to 2032

Figure 119: East Asia  Attractiveness Analysis, By Country, 2022 to 2032

Figure 120: China  Value Proportion Analysis, 2022

Figure 121: Global Vs. China Growth Comparison, 2021 to 2032

Figure 122: China  Share Analysis (%) By Product, 2021 to 2032

Figure 123: China  Share Analysis (%) by Application, 2021 to 2032

Figure 124: China  Share Analysis (%) by End User, 2021 to 2032

Figure 125: Japan  Value Proportion Analysis, 2022

Figure 126: Global Vs. Japan Growth Comparison, 2021 to 2032

Figure 127: Japan  Share Analysis (%) By Product, 2021 to 2032

Figure 128: Japan  Share Analysis (%) by Application, 2021 to 2032

Figure 129: Japan  Share Analysis (%) by End User, 2021 to 2032

Figure 130: South Korea  Value Proportion Analysis, 2022

Figure 131: Global Vs. South Korea Growth Comparison, 2021 to 2032

Figure 132: South Korea  Share Analysis (%) By Product, 2021 to 2032

Figure 133: South Korea  Share Analysis (%) by Application, 2021 to 2032

Figure 134: South Korea  Share Analysis (%) by End User, 2021 to 2032

Figure 135: South Asia  Value (US$ Million) Analysis, 2012 to 2021

Figure 136: South Asia  Value (US$ Million) Forecast, 2022 to 2032

Figure 137: South Asia  Value Share, By Product (2022 E)

Figure 138: South Asia  Value Share, by Application (2022 E)

Figure 139: South Asia  Value Share, by End User (2022 E)

Figure 140: South Asia  Value Share, by Country (2022 E)

Figure 141: South Asia  Attractiveness Analysis, By Product, 2022 to 2032

Figure 142: South Asia  Attractiveness Analysis, By Application, 2022 to 2032

Figure 143: South Asia  Attractiveness Analysis, By End User, 2022 to 2032

Figure 144: South Asia  Attractiveness Analysis, By Country, 2022 to 2032

Figure 145: India  Value Proportion Analysis, 2022

Figure 146: Global Vs. India Growth Comparison, 2021 to 2032

Figure 147: India  Share Analysis (%) By Product, 2021 to 2032

Figure 148: India  Share Analysis (%) by Application, 2021 to 2032

Figure 149: India  Share Analysis (%) by End User, 2021 to 2032

Figure 150: Indonesia  Value Proportion Analysis, 2022

Figure 151: Global Vs. Indonesia Growth Comparison, 2021 to 2032

Figure 152: Indonesia  Share Analysis (%) By Product, 2021 to 2032

Figure 153: Indonesia  Share Analysis (%) by Application, 2021 to 2032

Figure 154: Indonesia  Share Analysis (%) by End User, 2021 to 2032

Figure 155: Malaysia  Value Proportion Analysis, 2022

Figure 156: Global Vs. Malaysia Growth Comparison, 2021 to 2032

Figure 157: Malaysia  Share Analysis (%) By Product, 2021 to 2032

Figure 158: Malaysia  Share Analysis (%) by Application, 2021 to 2032

Figure 159: Malaysia  Share Analysis (%) by End User, 2021 to 2032

Figure 160: Thailand  Value Proportion Analysis, 2022

Figure 161: Global Vs. Thailand Growth Comparison, 2021 to 2032

Figure 162: Thailand  Share Analysis (%) By Product, 2021 to 2032

Figure 163: Thailand  Share Analysis (%) by Application, 2021 to 2032

Figure 164: Thailand  Share Analysis (%) by End User, 2021 to 2032

Figure 165: Oceania  Value (US$ Million) Analysis, 2012 to 2021

Figure 166: Oceania  Value (US$ Million) Forecast, 2022 to 2032

Figure 167: Oceania  Value Share, By Product (2022 E)

Figure 168: Oceania  Value Share, by Application (2022 E)

Figure 169: Oceania  Value Share, by End User (2022 E)

Figure 170: Oceania  Value Share, by Country (2022 E)

Figure 171: Oceania  Attractiveness Analysis, By Product, 2022 to 2032

Figure 172: Oceania  Attractiveness Analysis, By Application, 2022 to 2032

Figure 173: Oceania  Attractiveness Analysis, By End User, 2022 to 2032

Figure 174: Oceania  Attractiveness Analysis, By Country, 2022 to 2032

Figure 175: Australia  Value Proportion Analysis, 2022

Figure 176: Global Vs. Australia Growth Comparison, 2021 to 2032

Figure 177: Australia  Share Analysis (%) By Product, 2021 to 2032

Figure 178: Australia  Share Analysis (%) by Application, 2021 to 2032

Figure 179: Australia  Share Analysis (%) by End User, 2021 to 2032

Figure 180: New Zealand  Value Proportion Analysis, 2022

Figure 181: Global Vs. New Zealand Growth Comparison, 2021 to 2032

Figure 182: New Zealand  Share Analysis (%) By Product, 2021 to 2032

Figure 183: New Zealand  Share Analysis (%) by Application, 2021 to 2032

Figure 184: New Zealand  Share Analysis (%) by End User, 2021 to 2032

Figure 185: Middle East & Africa  Value (US$ Million) Analysis, 2012 to 2021

Figure 186: Middle East & Africa  Value (US$ Million) Forecast, 2022 to 2032

Figure 187: Middle East & Africa  Value Share, By Product (2022 E)

Figure 188: Middle East & Africa  Value Share, by Application (2022 E)

Figure 189: Middle East & Africa  Value Share, by End User (2022 E)

Figure 190: Middle East & Africa  Value Share, by Country (2022 E)

Figure 191: Middle East & Africa  Attractiveness Analysis, By Product, 2022 to 2032

Figure 192: Middle East & Africa  Attractiveness Analysis, By Application, 2022 to 2032

Figure 193: Middle East & Africa  Attractiveness Analysis, By End User, 2022 to 2032

Figure 194: Middle East & Africa  Attractiveness Analysis, By Country, 2022 to 2032

Figure 195: GCC Countries  Value Proportion Analysis, 2022

Figure 196: Global Vs. GCC Countries Growth Comparison, 2021 to 2032

Figure 197: GCC Countries  Share Analysis (%) By Product, 2021 to 2032

Figure 198: GCC Countries  Share Analysis (%) by Application, 2021 to 2032

Figure 199: GCC Countries  Share Analysis (%) by End User, 2021 to 2032

Figure 200: Turkey  Value Proportion Analysis, 2022

Figure 201: Global Vs. Turkey Growth Comparison, 2021 to 2032

Figure 202: Turkey  Share Analysis (%) By Product, 2021 to 2032

Figure 203: Turkey  Share Analysis (%) by Application, 2021 to 2032

Figure 204: Turkey  Share Analysis (%) by End User, 2021 to 2032

Figure 205: South Africa  Value Proportion Analysis, 2022

Figure 206: Global Vs. South Africa Growth Comparison, 2021 to 2032

Figure 207: South Africa  Share Analysis (%) By Product, 2021 to 2032

Figure 208: South Africa  Share Analysis (%) by Application, 2021 to 2032

Figure 209: South Africa  Share Analysis (%) by End User, 2021 to 2032

Frequently Asked Questions

What is the current size of the global single-photon emission computed tomography market?

The global single-photon emission computed tomography market is expected to reach worth USD 2.45 Billion in 2022.

What is the sales forecast for the single-photon emission computed tomography through 2032?

The single-photon emission computed tomography is expected to reach USD 4.76 Billion by the end of 2032, with sales revenue expected to register a growth rate of 6.9% CAGR.

What are the key trends shaping the single-photon emission computed tomography market?

Rapid technological advancements, rise in volume of free standing imaging centers, and expanded applications for single-photon emission computed tomography in oncology are some of the key trends in the single-photon emission computed tomography market.

Which are the top 5 countries driving demand for the single-photon emission computed tomography?

The USA, Japan, China, Germany, and the Uk are expected to drive demand for single-photon emission computed tomography.

What is the growth projection for North America single-photon emission computed tomography market?

North America, spearheaded by the USA will continue to remain one of the key markets for single-photon emission computed tomography.

At what rate will the demand for single-photon emission computed tomography grow in South Asia?

Demand for single-photon emission computed tomography in South Asia is expected to grow at 7.7% CAGR over the next ten years.

At what rate is the demand for single-photon emission computed tomography expected to rise in Europe?

Demand for single-photon emission computed tomography in Europe is expected to register a growth of 6.8% during the forecast period.

Which countries are the key producers of single-photon emission computed tomography?

The USA, Japan, and China are the key producers of single-photon emission computed tomography.

Who are the key players in the single-photon emission computed tomography market sphere?

Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, Spectrum Dynamics Medical Inc., GE Healthcare, CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA, MEDICAL APPARATUS CO., LTD., PNPMed, NuCare Inc. are some of the key players in the single-photon emission computed tomography market.

At what rate did the single-photon emission computed tomography market expand from 2012 until 2021?

The market for single-photon emission computed tomography expanded at a CAGR rate of 5.4% during the historical years of 2012 to 2021.

Explore Similar Insights

Future Market Insights

Single-Photon Emission Computed Tomography Market